Dedifferentiated liposarcoma (DDLS) is a rare and aggressive soft tissue cancer with few effective treatment options. But now a clinical trial led by doctors from Memorial Sloan K ...

A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of ...

Targeted therapies are cancer medications that work more selectively than standard chemotherapy medications. They do this by targeting specific molecules or genetic changes in cancer cells in order to ...

Targeted therapies are medicines to treat cancer. They work differently than standard chemotherapy. Instead of killing all fast-growing cells or keeping them from dividing, targeted therapies work ...

New research shows a medication called daraxonrasib is helping people with advanced pancreatic cancer live longer.

The targeted therapy sunvozertinib was more effective than standard platinum-based chemotherapy as a first-line treatment for ...

The overall survival rate for people who got daraxonrasib was 13.2 months, nearly double the 6.7 months people survived on standard chemotherapy alone.

For the past 20 years, many of the dramatic improvements in cancer outcomes can be attributed to personalized cancer treatments based upon DNA mutations in a tumor. Targeted therapies — often one pill ...

Keaton Herzer tells PEOPLE a newer targeted therapy unexpectedly shrank his tumors enough to qualify for a liver transplant ...

NICE has recommended a new treatment option for adults with recurrent or metastatic cervical cancer that has progressed on or ...

Akeso (AKESF) said its experimental lung cancer treatment ivonescimab improved overall survival compared with a widely used ...

Here are some of the key gynecologic cancer presentations to watch at ASCO 2026.